InflaRx (IFRX) Income from Continuing Operations (2016 - 2026)

InflaRx has disclosed Income from Continuing Operations across 11 years of filings, most recently posting -$7.3 million for Q2 2026.

• In Q2 2026, Income from Continuing Operations rose 48.08% year-over-year to -$7.3 million; the TTM figure through Jun 2026 stood at -$40.3 million (up 59.29% YoY), while the FY2025 annual figure was -$51.5 million, down 4.71% from the prior year.
• Income from Continuing Operations came in at -$7.3 million for Q2 2026 at InflaRx, up from -$8.0 million in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of $621.0 billion in Q4 2022 to a low of -$55.9 million in Q4 2024.
• Average Income from Continuing Operations over 5 years is $34.5 billion, with a median of -$11.7 million recorded in 2023.
• Year-over-year, Income from Continuing Operations jumped 396.44% in 2022 and slumped 797.68% in 2023.
• Over 5 years, Income from Continuing Operations stood at $621.0 billion in 2022, then sank by 100.01% to -$47.1 million in 2023, then declined by 18.61% to -$55.9 million in 2024, then surged by 74.07% to -$14.5 million in 2025, then surged by 49.75% to -$7.3 million in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were -$7.3 million in Q2 2026, -$8.0 million in Q1 2026, and -$14.5 million in Q4 2025.